Data / Drug companies / Anthelmintic
Anthelmintic drugs: 4 drugs from 14 companies in the FDA NDC directory
Anthelmintic is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 14 products in this class from 14 companies, covering 4 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 11, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 14Companies
- 14Products
- 4Drugs by generic name
Drugs in the Anthelmintic class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Albendazole | 10 | 10 |
| Praziquantel | 2 | 2 |
| Mebendazole | 1 | 1 |
| Triclabendazole | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Actavis Pharma, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 13, 2019 |
| Alembic Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 11, 2024 |
| Alembic Pharmaceuticals Limited | 1 | tablet, film coated | Generic drugs (ANDA) | September 11, 2024 |
| Amneal Pharmaceuticals LLC | 1 | tablet, film coated | New drug applications (NDA) | June 11, 1996 |
| Amneal Pharmaceuticals of New York LLC | 1 | tablet, film coated | New drug applications (NDA) | June 11, 1996 |
| Bayer HealthCare Pharmaceuticals Inc. | 1 | tablet, film coated | New drug applications (NDA) | April 21, 2011 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | February 24, 2021 |
| Dr. Reddy's Laboratories Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | January 26, 2021 |
| Edenbridge Pharmaceuticals LLC. | 1 | tablet | Generic drugs (ANDA) | May 17, 2019 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | May 14, 2019 |
| Janssen Pharmaceuticals, Inc. | 1 | tablet, chewable | New drug applications (NDA) | October 20, 2016 |
| Novadoz Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | February 24, 2021 |
| Novartis Pharmaceuticals Corporation | 1 | tablet | New drug applications (NDA) | February 13, 2019 |
| Par Health USA, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | November 27, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 8 | 57.1% |
| Tablet | 5 | 35.7% |
| Tablet, chewable | 1 | 7.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.